| Bleomycin induces drug efflux in lungs. A pitfall for pharmacological studies of pulmonary fibrosis JK Park, NJ Coffey, SP Bodine, CN Zawatsky, L Jay, WA Gahl, G Kunos, ... American Journal of Respiratory Cell and Molecular Biology 62 (2), 178-190, 2020 | 25 | 2020 |
| Reconstitution of the S. aureus agr quorum sensing pathway reveals a direct role for the integral membrane protease MroQ in pheromone biosynthesis A Zhao, SP Bodine, Q Xie, B Wang, G Ram, RP Novick, TW Muir Proceedings of the National Academy of Sciences 119 (33), e2202661119, 2022 | 22 | 2022 |
| Bi-allelic TMEM94 truncating variants are associated with neurodevelopmental delay, congenital heart defects, and distinct facial dysmorphism J Stephen, S Maddirevula, S Nampoothiri, JD Burke, M Herzog, A Shukla, ... The American Journal of Human Genetics 103 (6), 948-967, 2018 | 22 | 2018 |
| CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome R Cinar, JK Park, CN Zawatsky, NJ Coffey, SP Bodine, J Abdalla, ... Clinical and Translational Medicine 11 (7), e471, 2021 | 20 | 2021 |
| Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility J Imani, SPM Bodine, AM Lamattina, DD Ma, S Shrestha, DM Maynard, ... Respiratory Research 23 (1), 167, 2022 | 2 | 2022 |
| Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndrome S Abudi-Sinreich, SP Bodine, T Yokoyama, NJ Tolman, M Tyrlik, LC Testa, ... Respiratory Research 23 (1), 112, 2022 | 2 | 2022 |
| Community behaviors of bacteria in flow: Divergent roles for transport and collective morphology KM Hallinen, SP Bodine, HA Stone, TW Muir, NS Wingreen, Z Gitai bioRxiv, 2023.11. 22.568348, 2023 | | 2023 |
| MRI-1867, Dual Target Cannabinoid Receptor 1 (CB1R) and Inducible Nitric Oxide Synthase (iNOS) Inhibitor, for Effective Anti-Fibrotic Therapy for Hermansky … R Cinar, MR Iyer, JK Park, CN Zawatsky, NJ Coffey, SP Bodine, J Abdalla, ... A28. RARE DISEASES ARE NOT RARE, A1198-A1198, 2020 | | 2020 |
| N-ACETYLMANNOSAMINE (MANNAC) THERAPY MITIGATES GLOMERULAR HYPOSIALYLATION AND PROTEINURIA M Huizing, JP Troost, P Leoyklang, SP Bodine, M Kretzler, WA Gahl, ... MOLECULAR GENETICS AND METABOLISM 127 (3), 275-276, 2019 | | 2019 |
| Effective Anti-Fibrotic Therapy for Hermansky-Pudlak Syndrome Pulmonary Fibrosis in Pale Ear Mice Using a Hybrid Inhibitor of Cannabinoid Receptor 1 (CB1R … R Cinar, NJ Coffey, S Bodine, JK Park, MR Iyer, BR Gochuico, WA Gahl, ... A29. EMERGING CONCEPTS IN LUNG FIBROSIS, A1227-A1227, 2019 | | 2019 |
| N-ACETYLNIANNOSAMINE (MANNAC) THERAPY MITIGATES GLOMERULAR HYPOSIALYLATION AND PROTEINURIA M Huizing, JP Troost, P Leoyklang, SP Bodine, M Kretzler, WA Gahl, ... MOLECULAR GENETICS AND METABOLISM 126 (3), 306-307, 2019 | | 2019 |
| Oropharyngeal Bleomycin Upregulates Drug Efflux Transporters and Reduces Lung Exposure to Substrate Compounds: A Pitfall for Pharmacological Studies on Pulmonary Fibrosis J Park, NJ Coffey, S Bodine, WA Gahl, MCV Malicdan, BR Gochuico, ... A68. MOLECULAR DETERMINANTS OF REMODELING IN LUNG FIBROSIS, A2222-A2222, 2018 | | 2018 |
| N-Acetylmannosamine Mitigates Neuraminidase-induced Podocyte Injury in Mice M Huizing, O Okafor, PM Zerfas, S Bodine, MF Starost, WA Gahl, JB Kopp, ... GLYCOBIOLOGY 25 (11), 1303-1304, 2015 | | 2015 |
| Oral N-acetylmannosamine reverses glomerular hyposialyation and ameliorates proteinuria in a mouse model of nephrotic syndrome MCV Malicdan, S Bodine, V Tanawattanacharoen, T Yokoyama, ... GLYCOBIOLOGY 24 (11), 1215-1215, 2014 | | 2014 |
